Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
64%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
OZEM
21
HOLDINGS
67%
ALSO IN THNR
THNR
18
HOLDINGS
78%
ALSO IN OZEM
SECTOR DRIFT (OZEM minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in OZEM |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.8% | 12.2% | 12.2% |
 |
NOVO-NORDISK A/S-SPONS ADR | 11.9% | 8.8% | 8.8% |
|
PFIZER INC | 8.4% | 5.7% | 5.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 5.1% | 5.1% | 5.1% |
|
AMGEN INC | 4.9% | 6.3% | 4.9% |
OZEM Overweight Relative to THNR
 |
ASCLETIS PHARMA, INC. | 5.4% |
|
KAILERA THERAPEUTICS INC | 4.8% |
|
ELI LILLY & CO | 3.6% |
|
NOVO-NORDISK A/S-SPONS ADR | 3.1% |
 |
HANSOH PHARMACEUTICAL GROUP COMPANY | 2.7% |
|
PFIZER INC | 2.6% |
 |
THE UNITED LABORATORIES INTE | 2.5% |
|
MBX BIOSCIENCES INC | 2.0% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.4% |
|
SHIONOGI & CO LTD | 1.4% |
OZEM Underweight Relative to THNR
|
REGENERON PHARMACEUTICALS | -6.1% |
|
ABBVIE INC | -5.8% |
|
MERCK & CO. INC. | -5.2% |
|
GILEAD SCIENCES INC | -3.8% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.6% |
|
INNOVENT BIOLOGICS, INC. | -2.2% |
 |
ASTRAZENECA PLC | -1.6% |
|
AMGEN INC | -1.4% |
|
CHUGAI PHARMACEUTICAL CO LTD | 0.0% |
|
ZEALAND PHARMA A/S | 0.1% |